DRUG
Price
$43.27
Change
+$4.47 (+11.52%)
Updated
Sep 3 closing price
Capitalization
278.36M
WVE
Price
$8.00
Change
-$1.62 (-16.84%)
Updated
Sep 3 closing price
Capitalization
1.27B
63 days until earnings call
Interact to see
Advertisement

DRUG vs WVE

Header iconDRUG vs WVE Comparison
Open Charts DRUG vs WVEBanner chart's image
Bright Minds Biosciences
Price$43.27
Change+$4.47 (+11.52%)
Volume$35.15K
Capitalization278.36M
Wave Life Sciences
Price$8.00
Change-$1.62 (-16.84%)
Volume$11.12M
Capitalization1.27B
DRUG vs WVE Comparison Chart in %
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. WVE commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a StrongBuy and WVE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (DRUG: $38.80 vs. WVE: $9.62)
Brand notoriety: DRUG and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 74% vs. WVE: 70%
Market capitalization -- DRUG: $278.36M vs. WVE: $1.27B
DRUG [@Biotechnology] is valued at $278.36M. WVE’s [@Biotechnology] market capitalization is $1.27B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, both DRUG and WVE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 3 TA indicator(s) are bullish while WVE’s TA Score has 2 bullish TA indicator(s).

  • DRUG’s TA Score: 3 bullish, 5 bearish.
  • WVE’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, DRUG is a better buy in the short-term than WVE.

Price Growth

DRUG (@Biotechnology) experienced а -13.33% price change this week, while WVE (@Biotechnology) price change was -3.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

WVE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($1.27B) has a higher market cap than DRUG($278M). DRUG YTD gains are higher at: 7.718 vs. WVE (-22.231). DRUG has higher annual earnings (EBITDA): -8.94M vs. WVE (-134.84M). WVE has more cash in the bank: 208M vs. DRUG (51.4M). DRUG has less debt than WVE: DRUG (141K) vs WVE (21.7M). WVE has higher revenues than DRUG: WVE (93.9M) vs DRUG (0).
DRUGWVEDRUG / WVE
Capitalization278M1.27B22%
EBITDA-8.94M-134.84M7%
Gain YTD7.718-22.231-35%
P/E RatioN/AN/A-
Revenue093.9M-
Total Cash51.4M208M25%
Total Debt141K21.7M1%
FUNDAMENTALS RATINGS
WVE: Fundamental Ratings
WVE
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
43

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRUGWVE
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 21 days ago
85%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSDIX37.90-0.21
-0.55%
DWS Small Cap Growth Inst
MIGHX43.56-0.30
-0.68%
MFS Massachusetts Inv Gr Stk R3
EPSRX24.35-0.17
-0.69%
NYLI Epoch Global Equity Yield Class R6
INYDX22.28-0.17
-0.76%
Victory Pioneer Disciplined Growth Y
NGJCX18.95-0.31
-1.61%
Nuveen Global Real Estate Securities C

DRUG and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRUG has been loosely correlated with WVE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if DRUG jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRUG
1D Price
Change %
DRUG100%
-0.22%
WVE - DRUG
44%
Loosely correlated
+0.21%
IVA - DRUG
44%
Loosely correlated
-15.02%
PHMMF - DRUG
44%
Loosely correlated
N/A
TVGN - DRUG
32%
Poorly correlated
-2.20%
ATYR - DRUG
31%
Poorly correlated
+5.02%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with PRQR. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
+0.21%
PRQR - WVE
62%
Loosely correlated
+1.78%
KRRO - WVE
54%
Loosely correlated
-3.79%
OCUL - WVE
48%
Loosely correlated
+4.01%
KYMR - WVE
45%
Loosely correlated
-1.24%
DRUG - WVE
44%
Loosely correlated
-0.22%
More